Orange clinical trials
How each study uses orange is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the orange studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Orange
- 2
Studies by the year they started
3 studies that test it; most in 2014 (1)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 2
Eisai Co., Ltd. (1) · Minia University (1) · University of Rochester (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses orange is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Usage of Orange Peel Extract in Management of EpistaxisNot yet recruitingNot applicableMinia UniversityNCT06836102Written as Orange
- Aromatherapy for Chemotherapy-induced SymptomsTerminatedEarly Phase 1University of RochesterNCT02670941Written as Orange
- A Study of APD356 (Lorcaserin) in Healthy Japanese Adult SubjectsCompletedPhase 1Eisai Co., Ltd.NCT02192515Written as APD356 XR-20 mg (orange tablet)
Codes
What other systems call orange · ClinicalTrials.gg INT015068
- UNII (FDA) 5EVU04N5QUORANGEOne source FDA
- RxNorm 892565One source FDA
- NCI Thesaurus C65208OrangeOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 5EVU04N5QU | ORANGE | One source FDA |
| RxNorm | 892565 | — | One source FDA |
| NCI Thesaurus | C65208 | Orange | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.